Judge Expedites Icahn's Suit Over $3.5B Amylin Takeover Bid

Law360, New York (April 23, 2012, 2:48 PM EDT) -- A Delaware judge on Friday agreed to speed up Carl Icahn's efforts to nominate new members to Amylin Pharmaceuticals Inc.'s board, which the activist investor alleged shouldn't have rejected a lucrative $3.5 billion Bristol-Myers Squibb Co. takeover.

Vice Chancellor John W. Noble agreed to expedite the proceedings because he said Icahn had raised enough allegations that the board had abandoned its strategy of seeking a sale of the company without giving shareholders enough time to nominate their own board members to pursue the allegedly spurned Bristol-Myers...
To view the full article, register now.